Catalent
CTLT
#1520
Rank
ยฃ9.07 B
Marketcap
ยฃ50.02
Share price
0.65%
Change (1 day)
51.52%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total assets

Total assets on the balance sheet as of September 2024 : ยฃ7.64 Billion

According to Catalent's latest financial reports the company's total assets are ยฃ7.64 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Catalent - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2023-06-30ยฃ8.54 B-1.37%
2022-06-30ยฃ8.66 B31.58%
2021-06-30ยฃ6.58 B4.2%
2020-06-30ยฃ6.31 B29.69%
2019-06-30ยฃ4.87 B42%
2018-06-30ยฃ3.43 B29.21%
2017-06-30ยฃ2.65 B15.65%
2016-06-30ยฃ2.29 B15.07%
2015-06-30ยฃ1.99 B9.96%
2014-06-30ยฃ1.81 B-6.43%
2013-06-30ยฃ1.93 B-3.1%
2012-06-30ยฃ2.00 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ1.05 B-86.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.29 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.65 B 26.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ0.30 B-95.95%๐Ÿ‡บ๐Ÿ‡ธ USA